Decreasing incidence of femoral neck fractures in the Medicare population.
暂无分享,去创建一个
S. Kurtz | Thomas D Falls | K. Ong | E. Lau | A. Malkani | J. Day | K. Mackinlay | K. MacKinlay
[1] L. Melton,et al. Trends in Fracture Incidence: A Population‐Based Study Over 20 Years , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] N. Yurgin,et al. Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US , 2013, Applied Health Economics and Health Policy.
[3] Aitao Guo,et al. Randomized controlled trial of zoledronic acid for treatment of osteoporosis in women , 2013, The Journal of international medical research.
[4] R. Josse,et al. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis , 2013, Current medical research and opinion.
[5] F. Frihagen,et al. Hemiarthroplasty compared to internal fixation with percutaneous cannulated screws as treatment of displaced femoral neck fractures in the elderly: cost-utility analysis performed alongside a randomized, controlled trial , 2012, Osteoporosis International.
[6] Mark Stevenson,et al. Hemiarthroplasty and total hip arthroplasty for treating primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis. , 2011, Health technology assessment.
[7] S. Brophy,et al. Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.
[8] S. Cummings,et al. Secular trends in the incidence of hip and other osteoporotic fractures , 2011, Osteoporosis International.
[9] S. Molyneux,et al. The hidden blood loss after hip fracture. , 2011, Injury.
[10] N. Mahomed,et al. Fractures in the elderly: when is hip replacement a necessity? , 2010, Clinical interventions in aging.
[11] D. Ford,et al. One-year outcome for elderly patients with displaced intracapsular fractures of the femoral neck managed non-operatively. , 2010, Injury.
[12] Colin D J Hopley,et al. Primary total hip arthroplasty versus hemiarthroplasty for displaced intracapsular hip fractures in older patients: systematic review , 2010, BMJ : British Medical Journal.
[13] M. Weaver,et al. The Orthopaedic Implications of Diphosphonate Therapy , 2010, The Journal of the American Academy of Orthopaedic Surgeons.
[14] Edmund Lau,et al. Risk of Subsequent Revision after Primary and Revision Total Joint Arthroplasty , 2010, Clinical orthopaedics and related research.
[15] S. Kurtz,et al. Risk of Complication and Revision Total Hip Arthroplasty Among Medicare Patients with Different Bearing Surfaces , 2010, Clinical orthopaedics and related research.
[16] T. Prevost,et al. Symptomatic venous thromboembolism following a hip fracture , 2009, Acta orthopaedica.
[17] T. Therneau,et al. Secular trends in hip fracture incidence and recurrence , 2009, Osteoporosis International.
[18] J. Zuckerman,et al. Surgical Management of Hip Fractures: An Evidence‐based Review of the Literature. I: Femoral Neck Fractures , 2008, The Journal of the American Academy of Orthopaedic Surgeons.
[19] F. McKiernan,et al. Severely suppressed bone turnover and atypical skeletal fragility. , 2008, The Journal of clinical endocrinology and metabolism.
[20] L. Carbone,et al. Longitudinal Trends in Use of Bone Mass Measurement Among Older Americans, 1999–2005 , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] Clifford W Colwell,et al. Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition) , 2008 .
[22] N. Watts,et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy , 2008, Osteoporosis International.
[23] S. Kurtz,et al. Future clinical and economic impact of revision total hip and knee arthroplasty. , 2007, The Journal of bone and joint surgery. American volume.
[24] A. Lombardi,et al. Total hip arthroplasty after failed hip fractures: a challenging act. , 2007, Orthopedics.
[25] O. Furnes,et al. Total hip replacement after femoral neck fractures in elderly patients : Results of 8,577 fractures reported to the Norwegian Arthroplasty Register , 2007, Acta orthopaedica.
[26] S. Cummings,et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. , 2006, JAMA.
[27] P. Kannus,et al. Nationwide Decline in Incidence of Hip Fracture , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] J. Forbes,et al. Randomized comparison of reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty. Treatment of displaced intracapsular hip fractures in healthy older patients. , 2006, The Journal of bone and joint surgery. American volume.
[29] O. Johnell,et al. Primary arthroplasty is better than internal fixation of displaced femoral neck fractures: A meta-analysis of 14 randomized studies with 2,289 patients , 2006, Acta orthopaedica.
[30] C. Samama,et al. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study 1,2 , 2005, Journal of thrombosis and haemostasis : JTH.
[31] Linda Altizer,et al. Hip fractures , 2005, Orthopedic nursing.
[32] G. Hawker,et al. Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong? , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] J. Rodriguez-Portales,et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. , 2004, The New England journal of medicine.
[34] K. Gurusamy,et al. Internal fixation implants for intracapsular hip fractures in adults , 2001 .
[35] W. Gillespie. Hip fracture , 2001, BMJ : British Medical Journal.
[36] P Geusens,et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. , 2001, The New England journal of medicine.
[37] A. LaCroix,et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. , 1998, JAMA.
[38] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[39] M ROBURN,et al. Femoral neck fractures. , 1964, Lancet.
[40] O. Törring,et al. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate. , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[41] J. Dungan. Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur , 2011 .
[42] B. Morrey. Comparison of Bipolar Hemiarthroplasty with Total Hip Arthroplasty for Displaced Femoral Neck Fractures: A Concise Four-Year Follow-up of a Randomized Trial , 2011 .
[43] K. Gurusamy,et al. Cemented versus uncemented hemiarthroplasty for intracapsular hip fractures: A randomised controlled trial in 400 patients. , 2010, The Journal of bone and joint surgery. British volume.
[44] J. Dungan. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis , 2010 .
[45] J. Schneider. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. , 2009, Geriatrics.
[46] A Heinonen,et al. Epidemiology of hip fractures. , 1996, Bone.
[47] K. Choi. [Hip fracture]. , 1963, [Chapchi] Journal. Taehan Oekwa Hakhoe.